Nigeria's drug regulators face terror attacks

19 November 2007

Local offices of Nigeria's National Agency for Food and Drug Administration and Control have been vandalized or subjected to arson attacks and its Director General, Dora Akunyili, has survived an assassination attempt from pharmaceutical counterfeiters, during her six years in charge. Since a 2003 kidnap attempt on one of Mrs Akunyili's sons, much of her family has emigrated to the USA.

The NAFDAC's Director General since 2001, Mrs Akunyili is credited by many with reducing the fake drug problem in Nigeria. The UK's Guardian newspaper quoted a colleague at the World Health Organization as saying: "if the African continent were full of Doras, it would be easy to get rid of counterfeits." According to the Nigerian agency's figures, 41% of all drugs on the market in 2001 were estimated to be counterfeit copies. Last year, the rate was believed to have plunged to 16.7%, according to a survey of 600 drug samples taken across the country (Marketletter June 18).

The enforcement efforts of the NAFDAC have included 110 destruction exercises totaling fake drugs valued at $150.0 million and 45 convictions for trafficking since 2001.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight